EVair 03 (Jun-air) air compressor, model numbers: 1609000 and 1609002
FDA Device Recall #Z-0775-2024 - Class I, December 29, 2023
Recall Summary
| Recall Number | Z-0775-2024 |
| Classification | Class I - Serious risk |
| Date Initiated | December 29, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Datex-Ohmeda, Inc. |
| Location | Madison, WI |
| Product Type | Devices |
| Quantity | 12 units |
Product Description
EVair 03 (Jun-air) air compressor, model numbers: 1609000 and 1609002
Reason for Recall
GE HealthCare has become aware of elevated levels of formaldehyde when the EVair or EVair 03 (Jun-Air) optional compressors are used with the CARESCAPE R860 or Engstr¿m Carestation/Pro ventilators, respectively. These elevated results were observed in preliminary testing that was conducted at an elevated room temperature of 40oC (104oF), at the lowest possible flow condition of 2 L/min (worstcase, minimum bias flow with no additional ventilation), and all of the gas being supplied from the compressor (i.e., FiO2 of 21% / no supplemental oxygen). GE HealthCare is continuing to evaluate the root cause for these elevated levels of formaldehyde. While these test conditions are not representative of typical clinical use conditions,GE HealthCare is taking this action to further reduce the potential for patient exposure.
Distribution Pattern
Worldwide
Lot / Code Information
UDI/DI ********, Serial Numbers: CBCS01269, CBCT02328, CBCT03050, CBCT02306, CBCT02301, CBCT02303, CBCT02302, CBCT02088, CBCT02309, CBCT02304, CBCU00717, CBCU00559
Other Recalls from Datex-Ohmeda, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0076-2025 | Class I | Aespire 7900. This anesthesia gas machine is in... | Jul 12, 2024 |
| Z-0078-2025 | Class I | Avance. This anesthesia gas machine is intended... | Jul 12, 2024 |
| Z-0079-2025 | Class I | Amingo. OUS only. | Jul 12, 2024 |
| Z-0075-2025 | Class I | Aespire 100. This anesthesia gas machine is int... | Jul 12, 2024 |
| Z-0084-2025 | Class I | Auxiliary Common Gas Outlet (ACGO) conversion/i... | Jul 12, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.